CTRI/2021/01/030275招募中3 期
A randomized open label clinical study to evaluate the efficacy of Shunthyadam Vati in preventive cardiology on atherosclerotic cardiovascular disease (ASCVD) risk estimate using Framingham score.
Dr Abhijit Dinkarrao Shekhar0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patiens having signs and symptoms of Hridroga (cardiac diseases) having LDL levels greater than 130 mg/dl and total cholesterol greater than 160 mg/dl.
排除标准
- •patients with a 10 year fatal CVD RISK SCORE <1% AT the screening visit; acute myocardial infarction; unstable angina; evidence of any acute metabolic, vascular, infective complications; abnormal LFT and RFT; pregnant and lactating mother; known history of hemorrhagic stroke; known history of positive HIV test; laboratory findings during screening period suggesting positive hepatitis B ,POSITIVE SERUM OR URINE PREGNANCY TEST, ALT or AST >3x ULN, TSH ULN ,TRIGLYCERIDES > 400 mg/dl: abnormal life threatening ECG pattern and any other chronic diseases.
研究者
相似试验
尚未招募
2 期
A Clinical study to evaluate the efficacy and safety of Quista-DN health drink in diabetic individualsCTRI/2019/07/020179The Himalaya Drug Company
已完成
4 期
A clinical study to evaluate the efficacy and safety of Proseventy in dialysis patients.CTRI/2012/03/002516Panacea Biotec Ltd180
进行中（未招募）
不适用
Study to evaluate effect of ayurvedic dhoompana therapy in patient with lung cancer.CTRI/2018/05/014067Rasayani Cancer Clinics Pune30
进行中（未招募）
2 期
Management of Ankylosing Spondylitis through AyurvedaCTRI/2019/02/017768ational Institute of Ayurveda
已完成
2 期
A clinical study to see the effects and safety of PNB-001 in patients with moderate COVID-19 infectioCTRI/2020/10/028423PNB Vesper Life Science Pvt Ltd40